MedTrace Logo

Study on Risk Factors and Prognosis of MASLD

NCT07433205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 922

Last updated 2026-02-25

No results posted yet for this study

Summary

This longitudinal cohort study will enroll individuals with MASLD (and/or those at risk) and follow them over time to identify clinical and metabolic risk factors for disease progression and to evaluate predictors of long-term outcomes, including fibrosis progression and liver-related events, major cardiovascular events, and all-cause mortality.

Conditions

  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Sponsors & Collaborators

  • First Affiliated Hospital of Chongqing Medical University

    lead OTHER

Principal Investigators

  • Xuesong Doctor · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07433205 on ClinicalTrials.gov